Decreased baroreflex sensitivity assessed from phase IV of valsalva maneuver in mild congestive heart failure

Angiology

Volumn 50, Issue 8, 1999, Pages 655-664

  Rostagno, Carlo ^a   Felici, Massimo ^a   Caciolli, Sabina ^a   Olivo, Giuseppe ^a   Comeglio, Marco ^a   Galanti, Giorgio ^a   Serneri, Gian Gastone Neri ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE TEST; FEMALE; HEART CONTRACTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; SYMPATHETIC TONE; VALSALVA MANEUVER;

EID: 0032799890     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000806     Document Type: Article

References (38)

1. Thomas JA, Marks Bh: Plasma norepinephrine in congestive heart failure. Am J Cardiol. 41:233-243, 1978.
2. Cohn JN, Levine B, Olivari MT, et al: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819-823, 1984.
3. Hasking GJ, Esler MD, Jennings GL, et al: Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nerve activity. Circulation 73:615-621, 1986.
4. Leimbach WN, Wallin GB, Victor RG, et al: Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73:913-919, 1986.
5. Eckberg DL, Drabinsky M, Braunwald E: Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285:877-883, 1971.
6. Goldstein RE, Beiser GD, Stampfer M, et al: Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res. 36:571-578, 1975.
7. Olivari MT, Levine TB, Cohn JN: Abnormal neurohumoral response to nitroprusside in congestive heart failure. J Am Coll Cardiol 2:411-417, 1983.
8. Ellenbogen KA, Mohanty PK, Szentpetery S, et al: Arterial baroreflex abnormalities in heart failure: Reversal after orthotopic cardiac transplantation. Circulation 79:51-58, 1989.
9. Ferguson DW, Berg WJ, Roach PJ, et al: Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol 69:523-531, 1992.
10. Ferguson DW, Berg WJ, Sanders JS: Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct microneurographic recordings. J Am Coll Cardiol 16:1125-1134, 1990.
11. Benedict CR, Weiner DH, Johnstone DE, et al, for the SOLVD Investigators: Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the Studies of Left Ventricular Dysfunction (SOLVD) registry. J Am Coll Cardiol 22(suppl A):146A-153A, 1993.
12. Grassi G, Seravalle G, Cattaneo BM, et al: Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92:3206-3211, 1995.
13. Smith SA, Stallard TJ, Salih MM, et al: Can sinoaortic baroreceptor heart rate reflex sensitivity be determined from phase IV of the Valsalva manoeuvre? Cardiovasc Res 21:422-427, 1987.
14. Airaksinen KEJ, Hartikainen JEK, Niemela MJ, et al: Valsalva manoeuvre in the assessment of baroreflex sensitivity in patients with coronary artery disease. Eur Heart J 14:1519-1523, 1993.
15. Kautzner J, Hartikainen JEK, Camm AJ, et al: Arterial baroreflex sensitivity assessed from phase IV of the Valsalva maneuver. Am J Cardiol 78:575-579, 1996.
16. Pearlman AS, Gardin JM, Martin RP: Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography. Committee for Physician Training in Echocardiography. Am J Cardiol 60:158-163, 1987.
17. Stevenson JG: comparison of several noninvasive methods for estimation of pulmonary artery pressure. J Am Soc Echocardiogr 2:157-165, 1989.
18. Nishimura RA, Callahan MJ, Schaff HV, et al: Non invasive measurement of cardiac output by continuous wave Doppler echocardiography initial experience and review of literature. Mayo Clin Proc 59:484-490, 1984.
19. Ihlen H, Amlie JP, Dale J, et al: Determination of cardiac output by Doppler echocardiography. Br Heart J 51:54-70, 1984.
20. Lipkin DP, Scriven AJ, Crake T, et al: Six minutes walking test for assessing exercise capacity in chronic heart failure Br Med J 292:653-655, 1986.
21. Riley M, Mc Parland C, Stanford CF, et al: Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J 13:789-793, 1992.
22. Wassermann K: Determinants and detection of anaerobic threshold and consequences of exercise above it. Circulation 76(suppl VI):29-39, 1987.
23. Wassermann K: New concepts in assessing cardiovascular function. Circulation 78:1060-1071, 1988.
24. Wasserman K, Beaver LW, Whipp BJ: Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation 81:II14-II30, 1990.
25. Vanoli E, Adamson PB: Baroreflex sensitivity: Methods, mechanism and prognostic value. PACE 17(part II):434-445, 1994.
26. Farrell TG, Odemuyiwa O, Bashir Y: Prognostic value of baroreflex sensitivity testing after myocardial infarction. Br Heart J 67:129-137, 1992.
27. Trimarco B, Volpe M, Ricciardelli B: Valsalva maneuver in the assessment of baroreflex responsiveness in borderline hypertensives. Cardiology 70:6-14, 1983.
28. Francis GS, Benedict C, Johnstone DE, et al, for the SOLVD Investigators: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A sub-study of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82:1724-1729, 1990.
29. Rouleau JL, De Champlain J, Klein M, et al: Activation of neurohumoral systems in postinfarction left ventricular dysfunction J Am Coll Cardiol 22:390-398, 1993.
30. Mortara A, La Rovere MT, Pinna GD: Comparison of the reflex versus tonic vagal activity as predictors of six month survival in chronic heart failure. Eur Heart J 16(abs suppl):336, 1995.
31. Osterziel KJ, Hanlein D, Willenbrock R: Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73:517-522, 1995.
32. Sopher SM, Smith MI, Eckberg DL, et al: Autonomic pathophysiology in heart failure: Carotid baroreceptor-cardiac reflexes. Am J Physiol 259:H689-696, 1990.
33. Osterziel KJ, Dietz R, Schmid W, et al: ACE inhibition improves vagal reactivity in patients with heart failure. Am Heart J 120:1120-1129, 1990.
34. Guo GB, Abboud FM: Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 246:H80-89, 1984.
35. Caine AC, Lumbers ER, Reid IA: The effects and interactions of angiotensin and vasopressin on the heart of unanaesthetized sheep. J Physiol 367:1-11, 1985.
36. Vogt A, Unterberg C, Kreuzer H: Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure. Am J Cardiol 59:149D-153D, 1987.
37. Ferguson DW: Digitalis and neurohormonal abnormalities in heart failure and implications for therapy. Am J Cardiol 69:24G-33G, 1992.
38. Giannattasio C, Failla M, Stella ML, et al: Alterations of radial artery compliance in patients with congestive heart failure. Am J Cardiol 76:381-385, 1995.